WO2002025277A1 - Heart-lung machine provided with a device for electrical impedance measurement, and method therefore - Google Patents
Heart-lung machine provided with a device for electrical impedance measurement, and method therefore Download PDFInfo
- Publication number
- WO2002025277A1 WO2002025277A1 PCT/NL2001/000701 NL0100701W WO0225277A1 WO 2002025277 A1 WO2002025277 A1 WO 2002025277A1 NL 0100701 W NL0100701 W NL 0100701W WO 0225277 A1 WO0225277 A1 WO 0225277A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood
- φ
- rt
- transporting machine
- sd
- Prior art date
Links
- 238000002847 impedance measurement Methods 0 abstract claims description title 12
- 210000004369 Blood Anatomy 0 abstract claims description 94
- 239000008280 blood Substances 0 abstract claims description 94
- 239000011734 sodium Substances 0 claims description 14
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0 claims description 12
- 238000005534 hematocrit Methods 0 claims description 11
- 238000004422 calculation algorithm Methods 0 claims description 7
- 208000005189 Embolism Diseases 0 claims description 5
- 206010073734 Microembolism Diseases 0 claims description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyA+CjwhLS0gRU5EIE9GIEhFQURFUiAtLT4KPHJlY3Qgc3R5bGU9J29wYWNpdHk6MS4wO2ZpbGw6I0ZGRkZGRjtzdHJva2U6bm9uZScgd2lkdGg9Jzg1JyBoZWlnaHQ9Jzg1JyB4PScwJyB5PScwJz4gPC9yZWN0Pgo8dGV4dCB4PSczMy40OTE2JyB5PSc0OS41JyBzdHlsZT0nZm9udC1zaXplOjE0cHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojMDAwMDAwJyA+PHRzcGFuPlB0PC90c3Bhbj48L3RleHQ+Cjwvc3ZnPgo= [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0 claims description 4
- 239000010932 platinum Substances 0 claims description 4
- 206010001526 Air embolism Diseases 0 claims description 3
- 230000017531 blood circulation Effects 0 claims 2
- 229910052708 sodium Inorganic materials 0 description 10
- 230000002349 favourable Effects 0 description 5
- 239000002245 particles Substances 0 description 4
- 206010021113 Hypothermia Diseases 0 description 3
- 230000002631 hypothermal Effects 0 description 3
- 229910052697 platinum Inorganic materials 0 description 3
- 210000000170 Cell Membrane Anatomy 0 description 2
- 229940035295 Ting Drugs 0 description 2
- 239000003570 air Substances 0 description 2
- 230000002490 cerebral Effects 0 description 2
- 239000003814 drug Substances 0 description 2
- 230000000694 effects Effects 0 description 2
- 230000001965 increased Effects 0 description 2
- 230000003907 kidney function Effects 0 description 2
- 210000000709 Aorta Anatomy 0 description 1
- 210000000601 Blood Cells Anatomy 0 description 1
- 206010054938 Cerebral diseases Diseases 0 description 1
- 210000002216 Heart Anatomy 0 description 1
- 210000003734 Kidney Anatomy 0 description 1
- 210000004072 Lung Anatomy 0 description 1
- 229940069814 Mi-Omega Drugs 0 description 1
- 208000009025 Nervous System Diseases Diseases 0 description 1
- 229940067631 Phospholipids Drugs 0 description 1
- 210000004011 Plasma Cells Anatomy 0 description 1
- 206010038428 Renal diseases Diseases 0 description 1
- 230000004308 accommodation Effects 0 description 1
- 230000001154 acute Effects 0 description 1
- 230000002411 adverse Effects 0 description 1
- 239000011575 calcium Substances 0 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0 description 1
- 229910052791 calcium Inorganic materials 0 description 1
- 238000004364 calculation methods Methods 0 description 1
- 210000004027 cells Anatomy 0 description 1
- 238000006243 chemical reaction Methods 0 description 1
- 230000004087 circulation Effects 0 description 1
- 230000002596 correlated Effects 0 description 1
- 230000001419 dependent Effects 0 description 1
- 239000010410 layers Substances 0 description 1
- 238000002483 medication Methods 0 description 1
- 238000000034 methods Methods 0 description 1
- 230000004089 microcirculation Effects 0 description 1
- 150000003904 phospholipids Chemical class 0 description 1
- 229910052700 potassium Inorganic materials 0 description 1
- 239000011591 potassium Substances 0 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0 description 1
- 239000010970 precious metal Substances 0 description 1
- 108090000623 proteins and genes Proteins 0 description 1
- 102000004169 proteins and genes Human genes 0 description 1
- 230000002829 reduced Effects 0 description 1
- 230000003817 renal function Effects 0 description 1
- 230000000268 renotropic Effects 0 description 1
- 239000010935 stainless steel Substances 0 description 1
- 229910001220 stainless steel Inorganic materials 0 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/367—Circuit parts not covered by the preceding subgroups of group A61M1/3621
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
- A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/65—Impedance, e.g. conductivity, capacity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/02—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating the impedance of the material
Abstract
Description
HEART-LUNG MACHINE PROVIDED WITH A DEVICE FOR ELECTRICAL IMPEDANCE MEASUREMENT ,
AND METHOD THEREFORE
The present invention relates to a blood transporting machine as according to the heading of claim 1.
A blood transporting machine is used for extracorpo- real circulation of blood. Examples hereof are a heart- lung machine and an artificial kidney machine.
An open-heart operation is usually performed with a heart-lung machine (HLM) . Cerebral dysfunction and to a lesser extent kidney function disorders are frequently occurring problems for patients as a result of this operation. These cerebral and renal problems not only cause a greater or lesser degree of permanent invalidity for the patient, but also result in hospital accommodation costs in the short term and costs of care in the longer term.
One of the causes of renal and cerebral disorders is formed by a rise in the viscosity of the blood, which is caused by hypothermia and by the "acute phase" reaction generated in the body by the operation. Increased viscosity is linked to reduced cerebral microcirculation. Hyperviscosity resulting from hypothermia affects the renal function. In addition, the moments of canulating, manipulation of the heart and declamping of the aorta are significant surgical sources of the occurrence of micro- embolisms. Despite the use of different filters in conjunction with the HLM, a significant part of the micro- embolisms is still found to occur as a result of perfusi- on problems associated with the HLM.
The present invention has for its object to monitor the viscosity of blood when it is transported extracorpo- really by a blood transporting machine.
This objective is achieved with the present invention by providing a blood transporting machine of the above stated type, further comprising means for processing the impedance value to a viscosity value. The blood viscosity of a patient being treated can be measured with the blood transporting machine according to the invention.
It is favourable to embody the blood transporting machine as according to claim 2. It is hereby possible to monitor the blood viscosity value during open-heart operations. When the recorded blood viscosity value changes in adverse manner, external intervention can take place, for instance with medication.
Claim 3 is preferably applied. The electrical impe- dance measurement in the blood hereby takes place as soon as it is transported out of the blood transporting machine. A viscosity value for the blood is hereby obtained in a short time.
Claim 4 is preferably applied. Measuring of the impedance of the blood hereby becomes possible in efficient manner.
According to claim 5 the blood transporting machine is preferably embodied with a set of measuring electrodes . The impedance of the blood can hereby be measured between the measuring electrodes.
In the preferred embodiment the electrodes are circular. Such an embodiment allows the electrodes to enclose the perfusion tube.
The blood transporting machine is preferably embo- died with platinum electrodes. The use of platinum electrodes has a favourable effect on the accuracy of the value determination of the viscosity of the blood.
The electrodes are preferably arranged at a regular distance from each other in the longitudinal direction of the perfusion tube. A homogeneous electrical field in the blood is hereby achieved.
It is favourable to embody the heart-lung machine as according to claim 9. Such a ratio is effective for the homogeneity of the electrical field to be applied and measured.
The measure as according to claim 10 has a favourable effect on the accuracy of the measurement of the impedance value, and therefore on the accuracy of the blood viscosity to be determined.
In a preferred embodiment according to the invention the measure of claim 11 is applied in the blood transpor- ting machine. Particular medications administered to a patient when blood is circulated outside the body influence the sodium concentration in the blood of the patient. The sodium concentration influences the impedance of the blood. Inclusion of the sodium concentration in the algorithm for processing the impedance signal produces a more accurate determination of the viscosity value of the blood.
The invention also relates to and provides a.method for the operation of the heart-lung machine according to the invention. The method according to the invention relates in particular to detecting embolisms in the blood.
The method according to the invention preferably comprises of detecting air embolisms and/or micro-embo- lisms.
In a preferred embodiment according to the invention the blood transporting machine is embodied with temperature measuring means and means for measuring the haemato- crit value of the blood. These values can hereby also be monitored. The relation between the electrical impedance of the blood and the viscosity depends on the temperature and is also determined by the haematocrit value. For processing of the impedance signal to a viscosity value a calculation of the impedance signal is necessary with an algorithm dependent on the temperature and the haematocrit value.
It is favourable to determine correlation values for the relation between impedance of the blood and viscosity in relation to the temperature and the haematocrit value. The correlation coefficients are determined by doing an experiment with a large group of people. These are incorporated in the algorithm for processing the impedance signal to a viscosity value. An apparatus and a method for detecting the presence of embolisms in a tube through which blood or other fluid flows using a blood impedance measuring system is otherwise known from US 4,014,206. The invention is further elucidated with reference to the annexed figures, in which:
Figure 1 shows a schematic view of a preferred embodiment of the device for electrical impedance measurement of the blood in a heart-lung machine; Figure 2 shows a graph of a measurement signal for the impedance with the embodiment of figure 1 ;
Figure 3 shows a graph of an example of change in the impedance in accordance with a measurement with the embodiment of figure 1; Figure 4 shows a schematic view of a device for electrical impedance measurement of the blood, wherein particles flow in the blood;
Figure 5 shows a graph of the relation between impedance and viscosity corrected according to the inven- tion.
Figure 1 shows a schematic view of a preferred embodiment of the measuring device 1 for electrical impedance measurement of the blood in a blood transporting machine. The measuring device of the blood transpor- ting machine comprises two outer current electrodes 2,3 and two inner measuring electrodes 4,5 in the perfusion tube 6, immediately after the source from the blood transporting machine. Electrodes 2-5 are preferably circular and of platinum or stainless steel with a layer of precious metal. In order to obtain a homogeneous electrical field the distances between electrodes 2-5 are chosen so as to be more than twice the diameter of the perfusion tube 6 coming out of the blood transporting machine. By generating a low alternating current (10mA - 1mA) with a frequency between 4 kHz and 5000 kHz with an alternating current source 7 via the two outer electrodes 2,3, it will be possible via measuring electrodes 4,5 to continuously measure an impedance (ZO) of the blood passing the measuring electrodes. The impedance is acquired by measuring means 8.
Also shown is a sodium concentration measuring means 9 which is arranged in perfusion tube 6. Processing means 10 processes the measured value to a blood viscosity value which can be shown on a screen 11. The processing means can also be embodied to detect the occurrence of embolisms in the blood, air and/or micro-embolisms in particular. An example of an impedance signal as measured with the embodiment of figure 1 is shown in figure 2. A continuous recording of the change in the impedance signal (delta Z) can likewise take place. An example of a measurement signal of the change in the impedance signal is shown in figure 3.
It is known that blood has electrical properties. These electrical properties differ for plasma and blood cells. The plasma and the interior of the cells consist of conducting fluids with a determined electrical resis- tance and cell membranes consist of phospholipids and proteins with di-electrical properties. The electrical impedance of blood is determined primarily by three parameters: plasma resistance, internal resistance in the cell and the capacitance of the cell membrane. The elec- trical impedance of the blood increases with an increased viscosity of the blood. Just as the viscosity, the electrical impedance of blood increases during hypothermia and this is determined to a large degree by the haematocrit . Small particles (< 100 micron) with an impedance other than blood will become manifest in a sudden change in the impedance signal (Figures 2 + 3) . These changes can be seen particularly in the deltaZ signal and the magnitude of this change depends on the difference in specific resistance of the particles and of blood. During passage of air particles a large deflection will occur in the deltaZ signal in view of the clearly higher specific resistance of air relative to blood. This deflection of
H- tr rr tr ϋ 3 CO rt Ω <! H- g o φ rt z ?r rt Ω H- 3 SD o TJ rt μ- TJ rt CQ 0 m SD CQ TJ rt g Φ H Φ Φ H- 3" SD Φ 3 Φ K tr μ- 3 tr 3 Φ ϋ 3 ϋ tr φ • ϋ μ- d 3 3- g SD tr
TJ rt SD rt CQ i LQ Φ rt CQ 3 o Φ Φ O φ Φ rt Ω 1—1. CQ 0 K SD Φ O Ω Ω Φ SD ϋ Φ
Φ Z rt Z Φ H- 3 H- rt e rt Ω z CQ 0 Φ d tr o ? • <! CQ tr ^ Φ rt
U Φ H- Φ SD Ω H- 0 O Φ Φ CQ z rt *ϋ 3 Ω CQ CQ 0 h-1 g SD μ- Si CQ μ- Si w Φ O Φ ti S l-h rt 3 CO SD H- > ϋ SD SD 0 ≤ rt ≥; CQ rt Hi Φ r LQ Z Pi 0 SD μ- Φ CQ Ω φ
3 3 3 3 Ω rt H- * CQ rt P 0 rr 3 0 ii -> rt 3 H- tr 0 SD Φ 3 0 φ tr Φ Hi CQ 3 Hi φ Ω
Ω - K- Ω Φ CQ Ω 3^ 0 Pi rt CQ 1 rt rt Φ rt H P. CQ rt Φ i ϋ Φ rt
Φ rt 0 rt 0 SD M o 0 Ω rt Φ H- 0 Φ H- tr ^ 3 Z H- μ- rt μ- rt 3 μ- Φ 0 CQ SD
3- l-h 3* tr 3 3 3 tr Hi d tn tr CQ Ω 3 TJ O SD H- Ω 3 3* 3 tr μ- Ω Ω ϋ rt IS,
0 Φ Φ SD rt P. SD ϋ tr1 Φ TJ rt d H- i 3 rt SD Φ CQ φ Ω SD rt φ CQ 0 l-h Hi CQ CQ d rt < 3^ CQ 3 ϋ . — . Φ ϋ 0 0 3 Φ 0 3 h-1 3 rt ii μ- H rt μ- LQ - Hi CQ
H- H- 3 d ^ ti tr Φ φ CQ 0 rf TJ CQ ^ Si SD ^ LQ μ- 0 Φ 0 ii μ- tr 3 tr φ CQ Ω H- φ TJ Z tr 3 Φ TJ < SD CQ Φ Φ CQ rt tr rt Φ rt tr 3 1 3 φ rt 0 LQ
TJ SD ^ 3* h 3 CQ SD tr ^ Φ Φ SD H- i 3 Ω Φ H- tr Φ Φ tr rt TJ Φ Z φ tr rt 3
0 φ H- CQ 0 0 LQ 0 tr H Φ rt H Pi Hi SD Ω SD SD 3 ii i TJ φ φ g tr 0 Φ tr SD
0 Si 3 d z SD M 3 0 H- 3 g ^ •x] SD Φ rt 3 φ 3 Hi o μ- Φ ti μ- Si CJ1 Φ Hi Hi Φ u PJ 0 t 3 CQ SD Φ S 3 Φ 0 H- H- 0 Ω Ω rt Φ SD ϋ Φ 3 SD 0 rt ti CO ti
3 LQ Φ 3* 3 3 Mi SD P. LQ h-1 CQ 3 z Φ 0 rt tr tr * ii M rt 3 tr rt o TJ z
C Ω Φ α rt Φ tr SD H- 3 d φ 0 φ ϋ 3" Φ H- ^ . d SD 0 Ω μ- Φ 3- 3 φ Ω μ- φ Φ 3 tr 3 TJ O Qi rt CQ tr CQ O ii 3 CQ O Φ Ml CQ ϋ Φ CQ ii Φ Ω 0
Ω H- SD Ω SD 13 3 tr ii Ml Φ φ 0 TJ rt 0 0 Ω rt ϋ H μ- Φ rt 3 rt μ- 3 u SD rt 3 r ti H Φ si. SD SD H- 0 rt Hi Φ tr rt H- M SD !-r H- 3 0 tr SD CQ 0 μ- t Hl CQ
Φ 3 - TJ O H- 3 rt 3 3 Ml 3 ι . O H- Φ Φ tr 3 CQ Φ Hi 3 SD Φ rt ii 3 Φ μ- μ- tr
SD u SD φ ΓT Si 3 SD rt 0 0 — 3 Ω u ϋ Φ TJ l-1 φ Hi tr μ- tr TJ Ω CQ φ
CD rt 3" tr 3 rt H- LQ 0 3 rt Mi 3 ii Φ Φ SD Φ o CQ ii Ω 3 φ CQ rt
Φ r SD Φ SD Φ u tr Ω Φ 3 μ- tr 0 SD rt rt Z Si SD SD 3 ii rt ; 0 μ- rt 0 TJ H Φ O - H- 3 i H 3 SD Φ O 3 rt Φ H 3 tr tr H- SD >r H- rt Φ tr CQ Φ 3 Hi ^ rt SD Φ Φ 3 φ
Φ CQ Ω Φ SD P. M tr SD h-1 0 3 LQ ϋ SD CQ 3 SD ϋ H- 3 rt CD Hi 3 Ω CQ Ω CQ
SD Φ ϋ rt SD Ω LQ ii H- ϋ SD φ o 3 Φ Ω LQ Ω rt Ω Φ ζ μ- φ σ CQ Ω μ- μ- ■<! CQ
CQ TJ H- SD φ tr d Φ 3 H- H- rt d Φ φ H- 0 • SD 3 0 CQ ϋ ^ 3 φ Hi CQ
H- M 0 CQ H- 0 3 SD P- Φ 3 3 H- H- LQ rt SD CQ SD CQ rt φ SD μ- rt LQ rt CQ Φ Hi Φ Mi TJ o 3 SD d LQ φ 0 3 tr tr 3 CQ H- LQ ≤ Φ 0 μ- Φ 3 3 CQ Ω SD CQ ii tr Ω CQ SD ti H- Φ H Ω rt Ω tr 3 SD α !-■• 3 TJ d tr CQ H CO 3 rt φ μ- 3 d Φ φ O Φ tr tr H H φ H- H- P- rt tr rt rt rt LQ ϋ Φ 3 Ω SD LQ ii Ω Ω SD
CQ 3 tr H- M SD 3* 0 3 0 3J Φ SD tr tr Ω 3 rt Φ SD 3 r 3 CQ Hi 3 TJ 3 Φ φ tr rt
<! μ- ft 0 H- 3 μ- rt SD 0 3 LQ 1 Φ rt tr φ Φ 0 0 SD tr CQ 3 tr μ- ϋ CQ SD SD CO
H- rt •> 0 CQ 3 H- LQ Hi H- z 0 Mi 3 Φ Φ rt rt Φ Ω ϋ 0 Φ ϋ μ- 0 SD P. O ■ ; P- ? < o 0 H- rt SD 3 Ω φ d H- TJ CQ 3 tr ii d H) lP o rt CQ Hi CQ d
Ω D H- LQ 3 Ω rt 3J LQ T3 O φ rt 3 Φ tr H- TJ TJ rt s: Φ rt 0 Φ d Hi μ- Z rt ϋ
0 0 3 SD Ω rt Φ tr Φ Φ Φ SD 3 TJ i CQ ii Φ H- ϋ i 1 rt Φ Ω μ- SD Z μ- μ-
CQ l-h fi 3 0 H 3 ϋ Ω t f 3 Si LQ rt φ Hi 0 rt 0 i H- I-1 φ Φ Φ rt tr 3 rt 3 tr t- 3
H- u H. o 1 0 0 0 SD rt SD C rt tr Pi c 0 Φ ! Hi rt I-" SD 3 0 Φ Ω tr Φ I-" Ω μ- LQ rt rt rt H ϋ Φ 3 3 TJ CQ 3 tr Φ SD CQ Pi 3 H- C SD rt t CO μ- φ CQ φ Ω rt
^ 3J tr rt Φ tr Φ CQ TS tr ^ Ω SD Φ 3 H- Ω i CQ Z 3' ϋ 3 o Hi Φ φ rt 3* 3* TJ
Φ Φ t H- α -~ 0 SD φ rt Ω 0 ^ Φ μ- H- SD φ Φ 0 CQ Ω SD tr 0 Φ SD
SD ii Φ SD 0 d 3 H- rt ii H- 3 H- Φ 3 tr ■ 0 h-1 < 3 μ- ii TJ - tr i φ Hi Si CQ
3 tr φ rt Ω 0 Ω μ- O Φ 3 0 Φ SD 0 H- 3 Φ H- rt CQ SD SD φ ii μ- Ω CQ
Pi Mi Ω H- H- H- rt SD Ω 0 Φ 3 SD 3 CQ rt rt Mi 3 3 3 μ- ϋ Z H φ tr Hi SD SD
0 0 o 0 3 3 et g d SD CQ φ H- d CQ CQ tr rt Pi 0 CQ 3 rt μ- SD TJ Hi Hi CQ LQ
Ω 0 H 3 3 TS LQ H- Ω TS CQ CQ P. d rt LQ tr Z TJ H- ^ Φ 0 H- Mi CQ μ- Ω SD 0 0 φ Φ Φ
0 u Φ Ω φ H- 0 0 SD Φ d d ii Φ 3 Φ tr 'SD LQ CQ Ω 0 rt Ω -> rt CQ ii 0 ti
3 • Φ Si Mi 3 3 i P. ii ϋ H- ii SD CQ Φ ii 3" rt σ SD rt Hi SD φ CQ Φ i CQ 0 0
Ω 3 SD Hi CQ TS SD φ H- 3 3 rt rt Φ φ rt 3- 3 Φ SD ϋ μ- Hi Hi
Φ Hi 1 3 Φ rt 3 LQ O H- H- 3 H- Φ Ω CQ I-1 μ- 3 3 rt
3 tr Ω H 0 H- H- LQ Mi CQ φ "* CQ CQ iQ 0 0 Φ Φ 3 0 1 rt
rt
0
Ω ϋ μ- rt
<!
SD
H d
Φ
•
According to the invention a relation can be formulated between the viscosity value, the electrical impedance, the haematocrit value, the. temperature and the sodium level in the blood. The latter three factors influence the impedance of the blood. A test arrangement with blood from ten volunteers was used to establish correlation coefficients for said relation. The test arrangement simulated a heart-lung machine. Gelofusine was also added to change the haematocrit value. It was found that:
(1) Ln (visco) = 0.774 + 2876 x 10"2 x HCT - 2.104 x 10"2 x T + 2.765 x 10"3 X Na.
(2) Ln (imp.) = 5.466 + 2.386 x 10"2 x HCT - 1.961 x 10"2 x T - 5.995 x 10"3 x Na. (3) Visco = 0.364 + 3.782 x 10"2 x imp., wherein Ln is the natural logarithm, visco is the viscosity value, HCT the haematocrit value, T the temperature, Na the sodium level, and imp. the impedance according to the measurement. Measurement took place in the test arrangement with an alternating current with a frequency of 20 kHz and an alternating current value of 300 μA.
During the test arrangement the levels of Ht, sodium, potassium, calcium and the pH were measured. Of these variables only the sodium was found to have significant influence on the impedance/viscosity. For the processing of the impedance measurement to a viscosity value a correction is therefore necessary which depends on the measured sodium concentration.
The third formula shows a direct correlation between the viscosity value and the impedance measurement.
In figure 5 is shown the correlation between the viscosity and the impedance of a test measurement with the blood of ten people. The viscosity and impedance are shown to be correlated. The measurement of the impedance can be used to determine the viscosity value. The processing means are provided with an algorithm which calculates the relation according to formula (3) , wherein a correction for the measured sodium concentration is also carried out .
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1016247A NL1016247C2 (en) | 2000-09-22 | 2000-09-22 | Heart-lung machine provided with a device for electrical impedance measurement for the detection of microemboliÙn and / or fibrinogen concentration. |
NL1016247 | 2000-09-22 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU1438602A AU1438602A (en) | 2000-09-22 | 2001-09-24 | Heart-lung machine provided with a device for electrical impedance measurement, and method therefore |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002025277A1 true WO2002025277A1 (en) | 2002-03-28 |
Family
ID=19772129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2001/000701 WO2002025277A1 (en) | 2000-09-22 | 2001-09-24 | Heart-lung machine provided with a device for electrical impedance measurement, and method therefore |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1438602A (en) |
NL (1) | NL1016247C2 (en) |
WO (1) | WO2002025277A1 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005059532A1 (en) * | 2003-12-16 | 2005-06-30 | Dynabyte Informationssysteme Gmbh | Cartridge device for blood analysis |
EP2187201A1 (en) * | 2003-12-16 | 2010-05-19 | Dynabyte Informationssysteme GmbH | Cartridge device for blood analysis |
US20100153029A1 (en) * | 2007-01-08 | 2010-06-17 | Vibro-Meter, Inc. | System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank |
WO2011144511A1 (en) * | 2010-05-11 | 2011-11-24 | Fresenius Medical Care Deutschland Gmbh | Method and apparatus for determining cellular and/or extracellular, in particular macromolecular, portions of fluids, preferably bodily fluids, of living beings |
US8388546B2 (en) | 2006-10-23 | 2013-03-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US8388541B2 (en) | 2007-11-26 | 2013-03-05 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
US8393208B2 (en) | 2007-10-01 | 2013-03-12 | Meggitt (New Hampshire), Inc. | Measuring of fluid in a vessel with two coaxial cable sections and a coupling therebetween using time domain reflectometry |
US8437833B2 (en) | 2008-10-07 | 2013-05-07 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
US8478382B2 (en) | 2008-02-11 | 2013-07-02 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
US8512256B2 (en) | 2006-10-23 | 2013-08-20 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US8549909B2 (en) | 2007-10-01 | 2013-10-08 | Meggitt (Orange County), Inc. | Vessel probe connector with solid dielectric therein |
USD699359S1 (en) | 2011-08-09 | 2014-02-11 | C. R. Bard, Inc. | Ultrasound probe head |
US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
US8801693B2 (en) | 2010-10-29 | 2014-08-12 | C. R. Bard, Inc. | Bioimpedance-assisted placement of a medical device |
US8849382B2 (en) | 2007-11-26 | 2014-09-30 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
ITUD20130047A1 (en) * | 2013-04-03 | 2014-10-04 | Ct Di Riferimento Oncologico | Apparatus for the analysis of aggregate formation process in a biological fluid and its method of analysis |
US9125578B2 (en) | 2009-06-12 | 2015-09-08 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
US9211107B2 (en) | 2011-11-07 | 2015-12-15 | C. R. Bard, Inc. | Ruggedized ultrasound hydrogel insert |
US9339206B2 (en) | 2009-06-12 | 2016-05-17 | Bard Access Systems, Inc. | Adaptor for endovascular electrocardiography |
US9445734B2 (en) | 2009-06-12 | 2016-09-20 | Bard Access Systems, Inc. | Devices and methods for endovascular electrography |
WO2016152304A1 (en) * | 2015-03-20 | 2016-09-29 | ソニー株式会社 | Blood state monitoring device, method for monitoring blood state, blood state monitoring system, and blood state improving program |
US9456766B2 (en) | 2007-11-26 | 2016-10-04 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
US9492097B2 (en) | 2007-11-26 | 2016-11-15 | C. R. Bard, Inc. | Needle length determination and calibration for insertion guidance system |
US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
US9554716B2 (en) | 2007-11-26 | 2017-01-31 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
US9636031B2 (en) | 2007-11-26 | 2017-05-02 | C.R. Bard, Inc. | Stylets for use with apparatus for intravascular placement of a catheter |
US9649048B2 (en) | 2007-11-26 | 2017-05-16 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
US9839372B2 (en) | 2014-02-06 | 2017-12-12 | C. R. Bard, Inc. | Systems and methods for guidance and placement of an intravascular device |
US9901714B2 (en) | 2008-08-22 | 2018-02-27 | C. R. Bard, Inc. | Catheter assembly including ECG sensor and magnetic assemblies |
US10046139B2 (en) | 2010-08-20 | 2018-08-14 | C. R. Bard, Inc. | Reconfirmation of ECG-assisted catheter tip placement |
US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
US10449330B2 (en) | 2007-11-26 | 2019-10-22 | C. R. Bard, Inc. | Magnetic element-equipped needle assemblies |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4014206A (en) | 1975-03-31 | 1977-03-29 | Akron City Hospital | Apparatus and method for monitoring air emboli during extracorporeal circulation |
US4835477A (en) * | 1986-08-16 | 1989-05-30 | Fresenius Ag | Process for the determination of the hematocrit level of whole blood and apparatus for carrying out the process |
EP0542140A2 (en) * | 1991-11-15 | 1993-05-19 | Fresenius AG | Tube arrangement for use in a blood circuit |
WO2000074775A1 (en) * | 1999-06-03 | 2000-12-14 | Martil Instruments B.V. | Method, device and catheter for in vivo determining blood properties such as blood viscosity |
-
2000
- 2000-09-22 NL NL1016247A patent/NL1016247C2/en active Search and Examination
-
2001
- 2001-09-24 AU AU1438602A patent/AU1438602A/en active Pending
- 2001-09-24 WO PCT/NL2001/000701 patent/WO2002025277A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4014206A (en) | 1975-03-31 | 1977-03-29 | Akron City Hospital | Apparatus and method for monitoring air emboli during extracorporeal circulation |
US4835477A (en) * | 1986-08-16 | 1989-05-30 | Fresenius Ag | Process for the determination of the hematocrit level of whole blood and apparatus for carrying out the process |
EP0542140A2 (en) * | 1991-11-15 | 1993-05-19 | Fresenius AG | Tube arrangement for use in a blood circuit |
WO2000074775A1 (en) * | 1999-06-03 | 2000-12-14 | Martil Instruments B.V. | Method, device and catheter for in vivo determining blood properties such as blood viscosity |
Non-Patent Citations (1)
Title |
---|
VRIES DE P M J M ET AL: "IMPLICATIONS OF THE DIELECTRICAL BEHAVIOUR OF HUMAN BLOOD FOR CONTINUOUS ONLINE MEASUREMENT OF HAEMATOCRIT", MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING,GB,PETER PEREGRINUS LTD. STEVENAGE, vol. 31, no. 5, 1 September 1993 (1993-09-01), pages 445 - 448, XP000400532, ISSN: 0140-0118 * |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877510B2 (en) | 2003-12-16 | 2014-11-04 | F. Hoffmann-La Roche Ag | Method for conducting platelet aggregation analysis |
EP2187201A1 (en) * | 2003-12-16 | 2010-05-19 | Dynabyte Informationssysteme GmbH | Cartridge device for blood analysis |
US7901629B2 (en) | 2003-12-16 | 2011-03-08 | Dynabyte Informationssysteme Gmbh | Cartridge device for blood analysis |
US8591816B2 (en) | 2003-12-16 | 2013-11-26 | F. Hoffmann-La Roche Ag | Cartridge device for blood analysis |
US8465978B2 (en) | 2003-12-16 | 2013-06-18 | F. Hoffmann-La Roche Ag | Method for conducting platelete aggregation analysis by a cartridge device |
WO2005059532A1 (en) * | 2003-12-16 | 2005-06-30 | Dynabyte Informationssysteme Gmbh | Cartridge device for blood analysis |
US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
US10004875B2 (en) | 2005-08-24 | 2018-06-26 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
US8858455B2 (en) | 2006-10-23 | 2014-10-14 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US9833169B2 (en) | 2006-10-23 | 2017-12-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US9345422B2 (en) | 2006-10-23 | 2016-05-24 | Bard Acess Systems, Inc. | Method of locating the tip of a central venous catheter |
US8512256B2 (en) | 2006-10-23 | 2013-08-20 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US8774907B2 (en) | 2006-10-23 | 2014-07-08 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US8388546B2 (en) | 2006-10-23 | 2013-03-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US9265443B2 (en) | 2006-10-23 | 2016-02-23 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
US20100153029A1 (en) * | 2007-01-08 | 2010-06-17 | Vibro-Meter, Inc. | System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank |
US8794063B2 (en) | 2007-01-08 | 2014-08-05 | Meggitt (Orange County), Inc. | System and method for optimizing sweep delay and aliasing for time domain reflectometric measurement of liquid height within a tank |
US8549909B2 (en) | 2007-10-01 | 2013-10-08 | Meggitt (Orange County), Inc. | Vessel probe connector with solid dielectric therein |
US9453755B2 (en) | 2007-10-01 | 2016-09-27 | Meggitt (Orange County), Inc. | TDR fluid level sensor |
US8393208B2 (en) | 2007-10-01 | 2013-03-12 | Meggitt (New Hampshire), Inc. | Measuring of fluid in a vessel with two coaxial cable sections and a coupling therebetween using time domain reflectometry |
US9549685B2 (en) | 2007-11-26 | 2017-01-24 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
US10342575B2 (en) | 2007-11-26 | 2019-07-09 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
US10238418B2 (en) | 2007-11-26 | 2019-03-26 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
US10449330B2 (en) | 2007-11-26 | 2019-10-22 | C. R. Bard, Inc. | Magnetic element-equipped needle assemblies |
US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
US8849382B2 (en) | 2007-11-26 | 2014-09-30 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
US10231753B2 (en) | 2007-11-26 | 2019-03-19 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
US10165962B2 (en) | 2007-11-26 | 2019-01-01 | C. R. Bard, Inc. | Integrated systems for intravascular placement of a catheter |
US10105121B2 (en) | 2007-11-26 | 2018-10-23 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
US9999371B2 (en) | 2007-11-26 | 2018-06-19 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
US8388541B2 (en) | 2007-11-26 | 2013-03-05 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
US9681823B2 (en) | 2007-11-26 | 2017-06-20 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
US9649048B2 (en) | 2007-11-26 | 2017-05-16 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
US9636031B2 (en) | 2007-11-26 | 2017-05-02 | C.R. Bard, Inc. | Stylets for use with apparatus for intravascular placement of a catheter |
US9554716B2 (en) | 2007-11-26 | 2017-01-31 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
US9456766B2 (en) | 2007-11-26 | 2016-10-04 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
US9492097B2 (en) | 2007-11-26 | 2016-11-15 | C. R. Bard, Inc. | Needle length determination and calibration for insertion guidance system |
US9526440B2 (en) | 2007-11-26 | 2016-12-27 | C.R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
US8478382B2 (en) | 2008-02-11 | 2013-07-02 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
US8971994B2 (en) | 2008-02-11 | 2015-03-03 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
US9901714B2 (en) | 2008-08-22 | 2018-02-27 | C. R. Bard, Inc. | Catheter assembly including ECG sensor and magnetic assemblies |
US9907513B2 (en) | 2008-10-07 | 2018-03-06 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
US8437833B2 (en) | 2008-10-07 | 2013-05-07 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
US9445734B2 (en) | 2009-06-12 | 2016-09-20 | Bard Access Systems, Inc. | Devices and methods for endovascular electrography |
US9125578B2 (en) | 2009-06-12 | 2015-09-08 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
US9339206B2 (en) | 2009-06-12 | 2016-05-17 | Bard Access Systems, Inc. | Adaptor for endovascular electrocardiography |
US10271762B2 (en) | 2009-06-12 | 2019-04-30 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
US10231643B2 (en) | 2009-06-12 | 2019-03-19 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
WO2011144511A1 (en) * | 2010-05-11 | 2011-11-24 | Fresenius Medical Care Deutschland Gmbh | Method and apparatus for determining cellular and/or extracellular, in particular macromolecular, portions of fluids, preferably bodily fluids, of living beings |
US9823207B2 (en) | 2010-05-11 | 2017-11-21 | Fresenius Medical Care Deutschland Gmbh | Method and device for determining intracellular and/or extracellular, in particular macromolecular fractions of fluids, preferably of body fluids of living organisms |
US10046139B2 (en) | 2010-08-20 | 2018-08-14 | C. R. Bard, Inc. | Reconfirmation of ECG-assisted catheter tip placement |
US8801693B2 (en) | 2010-10-29 | 2014-08-12 | C. R. Bard, Inc. | Bioimpedance-assisted placement of a medical device |
US9415188B2 (en) | 2010-10-29 | 2016-08-16 | C. R. Bard, Inc. | Bioimpedance-assisted placement of a medical device |
USD699359S1 (en) | 2011-08-09 | 2014-02-11 | C. R. Bard, Inc. | Ultrasound probe head |
USD754357S1 (en) | 2011-08-09 | 2016-04-19 | C. R. Bard, Inc. | Ultrasound probe head |
US9211107B2 (en) | 2011-11-07 | 2015-12-15 | C. R. Bard, Inc. | Ruggedized ultrasound hydrogel insert |
WO2014162285A1 (en) * | 2013-04-03 | 2014-10-09 | Universita' Degli Studi Di Udine | Apparatus for analyzing the process of formation of aggregates in a biological fluid and corresponding method of analysis |
ITUD20130047A1 (en) * | 2013-04-03 | 2014-10-04 | Ct Di Riferimento Oncologico | Apparatus for the analysis of aggregate formation process in a biological fluid and its method of analysis |
US9839372B2 (en) | 2014-02-06 | 2017-12-12 | C. R. Bard, Inc. | Systems and methods for guidance and placement of an intravascular device |
WO2016152304A1 (en) * | 2015-03-20 | 2016-09-29 | ソニー株式会社 | Blood state monitoring device, method for monitoring blood state, blood state monitoring system, and blood state improving program |
US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
Also Published As
Publication number | Publication date |
---|---|
NL1016247C2 (en) | 2002-03-25 |
AU1438602A (en) | 2002-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8951219B2 (en) | Fluid volume monitoring for patients with renal disease | |
US5456253A (en) | Disposable extracorporeal conduit for blood constituent monitoring | |
JP4460805B2 (en) | Method for measuring intraperitoneal volume and peritoneal dialysis device | |
DE102004023080B4 (en) | Method and device for monitoring the supply of substitution fluid during extracorporeal blood treatment | |
EP1083948B1 (en) | Method for determining waste products in the dialysis liquid in dialysis treatment | |
JP3095223B2 (en) | Dialyzer | |
Depner et al. | Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution. | |
US8535522B2 (en) | System and method for detection of disconnection in an extracorporeal blood circuit | |
AU2005212146B2 (en) | Pressure sensing | |
US6887214B1 (en) | Blood pump having a disposable blood passage cartridge with integrated pressure sensors | |
US6514225B1 (en) | Dialysis pressure monitoring with clot suppression | |
AU698652B2 (en) | Method and system for optimizing dialysis clearance | |
US6599277B2 (en) | Aspiration flow meter and control | |
US20070088333A1 (en) | Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate | |
US7794419B2 (en) | Apparatus for controlling blood flow in an extracorporeal circuit | |
EP2194384B1 (en) | Method for determining the ion concentration of blood | |
JP3309094B2 (en) | Apparatus for reducing purge volume in a blood chemistry monitoring system | |
JP5357781B2 (en) | Improved signal detection for access disconnection systems | |
US4209392A (en) | Portable hepatic-assist method and apparatus for same | |
JP4148536B2 (en) | Device for calculating the efficiency of dialysis | |
EP2493526B1 (en) | Apparatus and method for detecting disconnection of an intravascular access device | |
JP4159250B2 (en) | Method and apparatus for calculating dialysis efficiency | |
KR19990029075A (en) | Hemodialysis monitor system for hemodialysis | |
EP1615680B1 (en) | Haemodialysis device | |
ES2206994T3 (en) | Method and device for monitoring access to a blood vessel during an extracorporeal blood treatment. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001982926 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001982926 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |